Sign up to save your podcasts
Or
Share THE RIDDLE OF DRUG RESPONSE: Why Does A Drug Work For One Person And Not Another?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
THE RIDDLE OF DRUG RESPONSE: Why Does A Drug Work For One Person And Not Another?
HOST: Hildy Grossman, CO-HOST: Jordan Rich
GUEST: Zachary Rogers, Ph.D. Postdoc at MIT | American Cancer Society Fellow
Lung cancer treatment is undergoing a revolution. In the last 15 years, we’ve transitioned from broad chemotherapy to precision medicine, targeting the specific genetic drivers of each patient’s cancer. This shift, along with the rise of immunotherapy, offers unprecedented hope. Today, we speak with Dr. Zachary Rogers, a post-doctoral researcher at MIT’s Koch Institute, whose work on ALK mutations illuminates these advancements. He’ll explain how targeted therapies and immunotherapies combat cancer, and delve into crucial questions: why do some patients respond while others don’t, and why does recurrence occur even after apparent remission? Dr. Rogers will also share insights into groundbreaking research on new cancer markers. Join us for a critical discussion on the future of lung cancer treatment – a conversation that provides a vital look at the forefront of cancer research.
View all episodes
By Upstage Lung Cancer
5
66 ratings
HOST: Hildy Grossman, CO-HOST: Jordan Rich
GUEST: Zachary Rogers, Ph.D. Postdoc at MIT | American Cancer Society Fellow
Lung cancer treatment is undergoing a revolution. In the last 15 years, we’ve transitioned from broad chemotherapy to precision medicine, targeting the specific genetic drivers of each patient’s cancer. This shift, along with the rise of immunotherapy, offers unprecedented hope. Today, we speak with Dr. Zachary Rogers, a post-doctoral researcher at MIT’s Koch Institute, whose work on ALK mutations illuminates these advancements. He’ll explain how targeted therapies and immunotherapies combat cancer, and delve into crucial questions: why do some patients respond while others don’t, and why does recurrence occur even after apparent remission? Dr. Rogers will also share insights into groundbreaking research on new cancer markers. Join us for a critical discussion on the future of lung cancer treatment – a conversation that provides a vital look at the forefront of cancer research.